Revenio represents Finnish health technology expertise on the international market

We use Finnish technology to improve the life expectancy and quality of life of people around the world. Health care megatrends, such as aging populations and a global need for cost savings, support our growth targets. We have strong evidence of the growth of net sales and our good level of profitability. We have an excellent operating profit margin. Approximately 56 per cent of our share capital is owned by private investors and briskly traded. We always seek to remember our owners and have a history of good dividend payment performance.

Why invest into Revenio?

1

We use Finnish technology to improve the life expectancy and quality of life of people around the world.

2

Health care megatrends, such as aging populations and a global need for cost savings, support our growth targets.

3

We have strong evidence of the growth of net sales and our good level of profitability. We have an excellent operating profit margin.

4

Approximately 56 per cent of our share capital is owned by private investors and briskly traded. We always seek to remember our owners and have a history of good dividend payment performance.

Financial guidance for 2018

Net sales growth is expected to remain strong. Profitability is expected to remain at a healthy level despite relatively increasing growth investments.

 

Image
Revenio innovaatio

Key financial figures

Dividend history (€)